The PMPRB protects and informs Canadians by ensuring that the prices of patented medicines sold in Canada are not excessive and by reporting on pharmaceutical trends.
/ Advocacy / PMPRB
Response to: Consultations on the PMPRB’s proposed changes (October 6, 2022)
Date: December 5, 2022
Subject: Request to postpone decision on July 15, 2021 PMPRB Guidelines changes
Date: October 14, 2021
Response to: Consultations on the PMPRB’s proposed changes (July 15, 2021) to definition
of gap medicines, references to comparator countries and the international price tests for
grandfathered medicines and their line extensions
Date: August 31, 2021
Subject: Consultations on the PMPRB’s proposed changes to definition of Gap medicines and timeline for compliance
Date: February 15, 2021
RE: Study on the impacts of the PMPRB
Date: November 6, 2020
Subject: BioAlberta’s submission to PMPRB guidelines consultation
Date: February 14, 2020
Subject: Regarding Proposed Changes to PMPRB Regulations
Date: August 24, 2019
Subject: On PMPRB reform, political leadership and evidence-based approach needed
Date: April 1, 2019
Subject: Regarding Proposed Reforms to the Patented Medicine Prices Review Board(PMPRB)Regulations
Date: March 7, 2019
RE: Representation concerning proposed changes to patented medicines regulations
Date: February 14, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: Serious concerns with proposed changes to Patented Medicines Regulations
Date: January 30, 2018
RE: PMPRB
Date: January 22, 2018
Subject: Regarding Patented Medicines Regulations Consultations
Date: October 17, 2017
Subject: A BioAlberta Briefing for Edmonton Mayor Don Iveson
Date: July 2017
Re: Response to Patented Medicines Regulations Consultations
Date: June 28, 2017
Subject: Regarding Health Canada conducting a review affecting the Life Sciences Industry
Date: June 27, 2017
Thank you to
Suite 202
10055 – 106 Street NW
Edmonton, AB, T5J 2Y2
Canada